Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Heves Surmeli Yapici"'
Autor:
Ozgur Tanriverdi, Serkan Menekse, Faysal Dane, Mukremin Uysal, Metin Ozkan, Halit Karaca, Mehmet Besiroglu, Ibrahim Vedat Bayoglu, Ayse Ocak Duran, Dogan Yazilitas, Alper Sevinc, Ilhan Hacibekiroglu, Erkan Arpaci, Aykut Bahceci, Mevlude Inanc, Heves Surmeli Yapici, Asude Aksoy
WOS: 000351058400056
PubMed ID: 25556478
Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this s
PubMed ID: 25556478
Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4644b7109f838e680f4e4429b7551933
https://hdl.handle.net/20.500.12809/3548
https://hdl.handle.net/20.500.12809/3548
